Formulation for intranasal administration

Details Formulation for intranasal administration Formulation for intranasal administration

1995-11-14

2000-01-25

MacMillan, Keith D.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Nitrogen containing other than solely as a nitrogen in an...

A61K 31135

Patent

active

060179635

ABSTRACT:
A dosage form for intranasal and/or inhalation administration of an analgesic having low opioid receptor binding activity to a warm blooded animal, that includes a pharmaceutically effective amount of the analgesic. A preferred analgesic is tramadol, a tramadol and/or a pharmaceutically acceptable salt, metabolite or derivative thereof. Methods of making and using the formulation according to the invention are also provided.

REFERENCES:
patent: 3652589 (1972-03-01), Flick et al.
patent: 4440777 (1984-04-01), Zupan
patent: 4464378 (1984-08-01), Hussain
patent: 4624965 (1986-11-01), Wenig
patent: 4729997 (1988-03-01), Wenig
patent: 4749700 (1988-06-01), Wenig
patent: 4778810 (1988-10-01), Wenig et al.
patent: 4880813 (1989-11-01), Frost
patent: 4973596 (1990-11-01), Cohen
patent: 5066648 (1991-11-01), Alexander et al.
patent: 5204119 (1993-04-01), Shiobara et al.
patent: 5223541 (1993-06-01), Maryanoff et al.
patent: 5336691 (1994-08-01), Raffa et al.
patent: 5446070 (1995-08-01), Mantelle
patent: 5451408 (1995-09-01), Mezei et al.
patent: 5468744 (1995-11-01), Raffa et al.
Chemical Abstracts AN: 108: 82103, Chrnbasik et al, "Analgesic use by Inhalation" corresponds to DE 3602370 A1, Aug. 6, 1986. Remington's Pharmaceutical Sciences, p. 1451, 1986.

Affiliated with

Also associated with

Rating

Formulation for intranasal administration does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Formulation for intranasal administration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Formulation for intranasal administration will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2316334